Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Tamoxifen in Advanced HR-High Breast Cancer
NCT03045653Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, sponsored by Sun Yat-sen University. Started Sep 2017; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03045653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045653.